AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

AN2 Therapeutics Inc. (ANTX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.40

-1.73%

After-hours Jan 03, 2025, 04:14 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	77.00K	n/a	n/a	n/a
Gross Profit	n/a	-77.00K	n/a	n/a	n/a
Operating Income	-69.64M	-42.26M	-21.57M	-7.28M	-5.18M
Interest Income	n/a	1.35M	69.00K	3.00K	n/a
Pretax Income	-64.73M	-40.96M	-21.54M	-13.60M	-5.63M
Net Income	-64.73M	-41.47M	-21.47M	-13.60M	-5.63M
Selling & General & Admin	14.76M	12.75M	4.67M	1.26M	289.00K
Research & Development	54.87M	29.51M	16.91M	6.02M	4.89M
Other Expenses	n/a	-45.00K	-38.00K	-6.32M	n/a
Operating Expenses	69.64M	42.26M	21.57M	7.28M	5.18M
Interest Expense	n/a	514.00K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	287.27K
Cost & Expenses	69.64M	42.26M	21.57M	7.28M	5.18M
Income Tax	n/a	514.00K	-69.00K	-3.00K	-31.07K
Shares Outstanding (Basic)	23.60M	19.40M	18.74M	18.74M	18.74M
Shares Outstanding (Diluted)	23.60M	19.40M	18.74M	18.74M	18.74M
EPS (Basic)	-2.74	-2.14	-1.15	-0.73	-0.3
EPS (Diluted)	-2.74	-2.14	-1.15	-0.73	-0.3
EBITDA	4.90M	-42.26M	n/a	-6.32M	n/a
Depreciation & Amortization	69.64M	77.00K	21.57M	7.28M	31.07M